AN INTRODUCTION TO THE CLINICAL TOXICOLOGY OF VOLATILE SUBSTANCES

被引:91
作者
FLANAGAN, RJ
RUPRAH, M
MEREDITH, TJ
RAMSEY, JD
机构
[1] Poisons Unit, Guy’S Hospital, London, SE14 5ER, Avonley Road
[2] Department of Health, Division of Toxicology and Environmental Health, London
[3] Toxicology Unit, Department of Clinical Epidemiology, St George’S Hospital Medical School, London
关键词
D O I
10.2165/00002018-199005050-00005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Acute poisoning with organic solvents and other volatile compounds now usually follows deliberate inhalation (volatile substance abuse) or ingestion of these compounds. Solvents from adhesives, typewriter correction and dry cleaning fluids, cigarette lighter refills (butane) and aerosol propellants are commonly abused. The major risk is that of sudden death. Arrhythmias leading to cardiac arrest are thought to cause most deaths, but anoxia, respiratory depression and vagal stimulation leading to cardiac arrest may also contribute, as may indirect causes such as aspiration of vomit or trauma. In the United Kingdom (UK), 3.5 to 10% of young people have at least experimented with volatile substance abuse and mortality is more than 100 per annum. The products abused are cheap and readily available despite legislation designed to limit supply. Volatile substance abuse is not illegal and only a minority of abusers are known to progress to heavy alcohol or illicit drug use. Prevention of abuse by education, not only of children but also of parents, teachers, retailers and health care workers, is important in limiting the problem. However, volatile substance abuse-related deaths are still increasing in the UK despite many measures aimed at prevention. Clinically, volatile substance abuse is characterised by a rapid onset of intoxication and rapid recovery. Euphoria and disinhibition may be followed by hallucinations, tinnitus, ataxia, confusion, nausea and vomiting. It is important not to further alarm the patient if signs of serious toxicity are present, since a cardiac arrest may be precipitated. Further exposure should be prevented and the patient resuscitated and given supplemental oxygen if necessary. Cardiac arrhythmias should be treated conventionally and respiratory failure managed supportively. Long term exposure to n-hexane is associated with the development of peripheral neuropathy, while prolonged abuse (notably of toluene or chlorinated solvents) can cause permanent damage to the central nervous system, heart, liver, kidney and lungs. Knowledge of the routes of absorption, distribution and excretion of volatile compounds, and of the rates governing these processes, is important in understanding the rate of onset, intensity and duration of intoxication, and rate of recovery after volatile substance abuse. In addition, such knowledge is helpful when the clinician is attempting to interpret the results of toxicological analyses performed on samples (blood, other tissues, urine) from such patients. Many volatile substances are partly metabolised, the metabolites being eliminated in exhaled air or in urine. Although metabolism normally results in detoxification, enhanced toxicity may also result as with carbon tetrachloride, chloroform, dichloromethane, n-hexane, trichloroethylene and possibly halothane. Identification of volatile substance abusers can be difficult, but the hair, breath and clothing may smell of solvent, and empty containers may be found. Perioral eczema (‘glue-sniffer’s rash’) from direct contact with glue poured into a plastic bag occurs rarely. Headspace gas chromatography of blood can detect exposure to many compounds but not to complex mixtures such as petrol; detection of metabolites is only useful with a few compounds, notably toluene, trichloroethylene and xylene. Prevalence studies suggest that volatile substance abuse is increasing worldwide yet the UK is the only country to collate and regularly publish data on abuse-related deaths. Such data, although difficult to collect, are important in identifying and monitoring the problem. A coordinated approach to the collation of analogous data on an international basis would be valuable in monitoring the efficacy of preventative programmes. © 1990, Adis International Limited. All rights reserved.
引用
收藏
页码:359 / 383
页数:25
相关论文
共 179 条
[1]  
Allister C., Lush M., Oliver J.S., Watson J.M., Status epilepticus caused by solvent abuse, British Medical Journal, 283, (1981)
[2]  
Altenkirch H., Kindermann W., Inhalant abuse and heroin addiction: a comparative study on 574 opiate addicts with and without a history of sniffing, Addictive Behaviours, 11, pp. 93-104, (1986)
[3]  
Altenkirch H., Mager J., Stoltenberg G., Helmbrecht J., Toxic polyneuropathies after sniffing a glue thinner, Journal of Neurology, 214, pp. 137-152, (1977)
[4]  
Andersen M.E., Pharmacokinetics of inhaled gases and vapours, Neurobehavioural Toxicology and Teratology, 3, pp. 383-389, (1981)
[5]  
Anderson H.R., Macnair R.S., Raey J.D., Deaths from abuse of volatile substances: a national epidemiological study, British Medical Journal, 290, pp. 304-307, (1985)
[6]  
Arlien-Soborg P., Henriksen L., Gade A., Gyldensted C., Paulson O.B., Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents, Acta Neurologica Scandinavica, 66, pp. 34-41, (1982)
[7]  
Arthur L.J.H., Curnock D.A., Xylene-induced epilepsy following innocent glue sniffing, British Medical Journal, 284, (1982)
[8]  
Astrand I., Uptake of solvents from the lungs, British Journal of Industrial Medicine, 42, pp. 217-218, (1985)
[9]  
Baader E.W., Tatigkeitsbericht der Abteilung für gewerbekrankheiten des Kaiserin Auguste/Victoria/Krankenhauses in Berlin/Lichtenberg, Zentralblatt Gewerberhygeine, 4, pp. 385-399, (1927)
[10]  
Baerg R.D., Kimberg D.V., Centrilobular hepatic necrosis and acute renal failure in ‘solvent sniffers’, Annals of Internal Medicine, 73, pp. 713-720, (1970)